A Prospective Study of Liquid Biopsy for Pancreatic Cancer Early Detection
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Xian-Jun Yu, M.D., Ph.D.
Fudan University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Department of General Sugery, Huadong Hospital
Shanghai, Shanghai Municipality, China
Recruiting - Department of Hepato-Biliary-Pancreatic-Splenic Surgery, Shanghai General Hospital
Shanghai, Shanghai Municipality, China
Jiang Long, M.D., Ph.D.Recruiting - Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University
Shanghai, Shanghai Municipality, China
Xianjun Yu, M.D., Ph.D.Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Dec 2023
- Primary completion
- 31 Oct 2026
- Completion
- 31 Mar 2027
- Last update posted
- 19 Sept 2024
- Registered enrollment
- 276
- Registry id
- NCT06166147
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.